prostatic hypertrophy การใช้

• It is used in the treatment of sex hormone-dependent conditions such as benign prostatic hypertrophy and endometrial cancer.
• Perkins is co-founder and Chairman of Procept, a company developing a biorobotic minimally invasive solution for benign prostatic hypertrophy.
• Spectrum terminated the development of Ozarelix, a luteinizing hormone releasing hormone antagonist for the treatment of benign prostatic hypertrophy in 2010.
• If your symptoms are due to a simple enlargement of the prostate, also called benign prostatic hypertrophy, herbal medicine can be very helpful.
• Recurrent infections may be caused by inefficient urination ( benign prostatic hypertrophy, neurogenic bladder ), prostatic stones or a structural abnormality that acts as a reservoir for infection.
• Prostatitis Awareness Week is observed from September 10 to September 16 and Benign Prostatic Hypertrophy ( BPH ) Awareness Week is observed from September 24 to September 30.
• In later life, a noncancerous growth of the gland called benign prostatic hypertrophy ( BPH ) may make it difficult to urinate or create the need to urinate frequently.
• Every effective treatment for baldness is a testosterone antagonist ( some, like finasteride, have label indications for treating benign prostatic hypertrophy on the same basis that they inhibit the action of testosterone ).
• It should not be used by people who have a history of drug abuse, have any cardiovascular disease, hyperthyroidism, glaucoma, peptic ulcers, prostatic hypertrophy, or epilepsy, or are pregnant, planning to become pregnant, or breast-feeding.
• Common causes include bladder dysfunction ( such as neurogenic bladder ) and urethral obstruction ( such as posterior urethral valves in male infants ) or compression ( such as from prostatic hypertrophy in older male adults ).
• The federal Food and Drug Administration has approved both drugs for treating enlargement of the prostate gland, a condition known as benign prostatic hypertrophy ( or hyperplasia ) that affects about half of men over age 50.
• Ephedrine should be used with caution in patients with inadequate fluid replacement, impaired adrenal function, hypoxia, hypercapnia, acidosis, hypertension, hyperthyroidism, prostatic hypertrophy, diabetes mellitus, cardiovascular disease, during delivery if maternal blood pressure is > 130 / 80 mmHg, and lactation.
• These symptoms may include testosterone is effective in counteracting these symptoms but is associated with a range of side effects, the most serious of which is enlargement of the prostate gland, which can lead to benign prostatic hypertrophy and even prostate cancer.
• "' Andarine "'( "'GTx-007 "', "'S-4 "') is an investigational selective androgen receptor modulator ( SARM ) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.
• Briefly, Stage I disease is cancer that is found incidentally in a small part of the sample when prostate tissue was removed for other reasons, such as benign prostatic hypertrophy, and the cells closely resemble normal cells and the gland feels normal to the examining finger.
• It is less potent in both anabolic and androgenic effects than other SARMs . In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects.
• The use of sildenafil and an ? 1 blocker ( typically prescribed for hypertension or for urologic conditions, such as benign prostatic hypertrophy ) at the same time may lead to low blood pressure, but this effect does not occur if they are taken at least 4 hours apart.
• SARMs are a new class of drugs which produce tissue-specific anabolic effects in some tissues such as muscle and bone, but without stimulating androgen receptors in other tissues such as in the prostate gland, thus avoiding side effects such as benign prostatic hypertrophy which can occur following treatment with unselective androgens like testosterone or anabolic steroids.